The objective of this research is to use the bovine growth hormone (bGH) and bovine prolactin (bPRL) genes to study three aspects of post-transcriptional gene regulation that influence the steady-- state levels of their corresponding messenger RNAs. (1) The bGH primary transcript is alternatively processed such that the last intron (intron D) is not removed. Apparently functional mRNAs containing intron D are found on polysomes in both pituitary and transfected tissue culture cells. Such mRNAs are predicted to code for an altered form of bGH in which the carboxy domains (108aa) are different from wild type. We will analyze nucleotide signal sequence in the downstream exon which influence this splicing event along with factors which interact with these sequences using site-directed mutagenesis, transfection systems and cell-free extract. Antisera generated against peptides contained within the carboxy domain will be used to study the variant form of growth hormone arising from this alternate splicing event. (2) The high efficiency of the bGH polyadenylation signal, coupled with its short effective sequence of only 52 nucleotides, renders it a good target for characterizing the essential elements required for efficient polyadenylation. A short downstream UGU sequence, which is known to be a critical component of this polyadenylation signal, and a strong stem structure which brackets the AAUAAA consensus signal will be targets for modification by in vitro mutagenesis. Mutants will be tested by an analytical procedure that allows accurate comparisons of polyadenylation efficiency both in cells and in cell-free extract. (3) A new approach for measuring the half-life of long-lived mRNAs that utilizes the inducible hsp70 promoter will be used to identify those features of bGH and bPRL mRNAs that contribute to their unusual stability. The availability of this assay will allow determination of hypothesized stability elements in these messages and the behavior of these sequences in the presence of known mRNA instability signals Collectively, characterization of these three post-transcriptional aspects of gene regulation will help to clarify the mechanisms where by the pituitary hormone messages reach such high steady- state level. Furthermore, they will provide a better understanding of intrinsic signals in mRNA that influence message steady state levels.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK032770-09
Application #
3231127
Study Section
Biochemistry Study Section (BIO)
Project Start
1983-08-01
Project End
1993-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Li, X; Shambaugh, M E; Rottman, F M et al. (2000) SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro. RNA 6:1847-58
Dirksen, W P; Li, X; Mayeda, A et al. (2000) Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer. J Biol Chem 275:29170-7
Stallings-Mann, M L; Ludwiczak, R L; Klinger, K W et al. (1996) Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. Proc Natl Acad Sci U S A 93:12394-9
Dirksen, W P; Sun, Q; Rottman, F M (1995) Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J Biol Chem 270:5346-52
Dirksen, W P; Hampson, R K; Sun, Q et al. (1994) A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J Biol Chem 269:6431-6
Sun, Q; Hampson, R K; Rottman, F M (1993) In vitro analysis of bovine growth hormone pre-mRNA alternative splicing. Involvement of exon sequences and trans-acting factor(s). J Biol Chem 268:15659-66
Sun, Q; Mayeda, A; Hampson, R K et al. (1993) General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev 7:2598-608
Salata, R A; Malhotra, I J; Hampson, R K et al. (1992) Application of an immune-tolerizing procedure to generate monoclonal antibodies specific to an alternate protein isoform of bovine growth hormone. Anal Biochem 207:142-9
Goodwin, E C; Rottman, F M (1992) The 3'-flanking sequence of the bovine growth hormone gene contains novel elements required for efficient and accurate polyadenylation. J Biol Chem 267:16330-4
Helms, S R; Rottman, F M (1990) Characterization of an inducible promoter system to investigate decay of stable mRNA molecules. Nucleic Acids Res 18:255-9

Showing the most recent 10 out of 12 publications